JK

Janusz Jozef Kulagowski

Merck: 50 patents #106 of 9,382Top 2%
Johnson & Johnson: 10 patents #997 of 7,810Top 15%
CS Chiesi Farmaceutici S.P.A.: 4 patents #81 of 341Top 25%
FA F. Hoffmann-La Roche Ag: 1 patents #201 of 425Top 50%
Overall (All Time): #32,856 of 4,157,543Top 1%
66
Patents All Time

Issued Patents All Time

Showing 26–50 of 66 patents

Patent #TitleCo-InventorsDate
6271230 Use of NK-1 receptor antagonists for treating cognitive disorders Raymond Baker, Jason Matthew Elliott, Neil Roy Curtis, Timothy Harrison, Gregory John Hollingworth +5 more 2001-08-07
6225320 Spiro-azacyclic derivatives and their use as therapeutic agents Piotr Raubo, Christopher John Swain, Christopher Thomson 2001-05-01
6172077 Spiro-azacyclic derivatives and their use as therapeutic agents Neil Roy Curtis, Jason Matthew Elliott, Gregory John Hollingworth, Philip Stephen Jackson, Eileen Mary Seward +2 more 2001-01-09
6114315 Use of NK-1 receptor antagonists for treating major depressive disorders with anxiety Raymond Baker, Neil Roy Curtis, Jason Matthew Elliott, Timothy Harrison, Gregory John Hollingworth +5 more 2000-09-05
6100256 Use of NK-1 receptors antagonists for treating schizophrenic disorders Raymond Baker, Neil Roy Curtis, Jason Matthew Elliott, Timothy Harrison, Gregory John Hollingworth +5 more 2000-08-08
6096729 Use of NK-1 receptor antagonists for treating amnestic disorders Raymond Baker, Neil Roy Curtis, Jason Matthew Elliott, Timothy Harrison, Gregory John Hollingworth +5 more 2000-08-01
6087348 Use of NK-1 receptor antagonists for treating stress disorders Raymond Baker, Neil Roy Curtis, Jason Matthew Elliott, Timothy Harrison, Gregory John Hollingworth +5 more 2000-07-11
6071928 Spiro-piperidine derivatives and their use as therapeutic agents Neil Roy Curtis, Ian Thomas Huscroft, Christopher John Swain 2000-06-06
6071927 Spiro-piperidine derivatives and their use as therapeutic agents Raymond Baker, Neil Roy Curtis, Jason Matthew Elliott, Timothy Harrison, Gregory John Hollingworth +4 more 2000-06-06
5977104 Use of NK-1 receptor antagonists for treating bipolar disorders Raymond Baker, Neil Roy Curtis, Jason Matthew Elliott, Timothy Harrison, Gregory John Hollingworth +5 more 1999-11-02
5952315 Use of NK-1 receptor antagonists for treating bipolar disorders Raymond Baker, Neil Roy Curtis, Jason Matthew Elliott, Timothy Harrison, Gregory John Hollingworth +5 more 1999-09-14
5929054 Use of NK-1 receptor antagonists for treating sexual dysfunctions Raymond Baker, Neil Roy Curtis, Jason Matthew Elliott, Timothy Harrison, Gregory John Hollingworth +5 more 1999-07-27
5925627 Use of NK-1 receptor antagonists for treating movement disorders Raymond Baker, Neil Roy Curtis, Jason Matthew Elliott, Timothy Harrison, Gregory John Hollingworth +5 more 1999-07-20
5919781 Use of NK-1 receptor antogonists for treating substance use disorders Raymond Baker, Neil Roy Curtis, Jason Matthew Elliott, Timothy Harrison, Gregory John Hollingworth +5 more 1999-07-06
5861407 Tetrahydropyridine derivatives as dopamine receptor subtype ligands Neil Roy Curtis, Paul D. Leeson, Ian M. Mawer, Mark Peter Ridgill 1999-01-19
5849765 Tetrahydropyridine derivatives as dopamine receptor subtype ligands Neil Roy Curtis, Paul D. Leeson, Kevin W. Moore, Andrew Pate Owens, Martin Teall 1998-12-15
5830901 Tetrahydropyridinylmethyl derivatives of pyrrolo2,3-B!pyridine Neil Roy Curtis, Paul D. Leeson, Mark Peter Ridgill 1998-11-03
5814644 Indole derivatives as dopamine D4 antagonists Paul D. Leeson, Mark Peter Ridgill 1998-09-29
5792768 Antipsychotic benzimidazole derivatives Paul D. Leeson 1998-08-11
5780475 Antipsychotic indazole derivatives Raymond Baker, Paul D. Leeson, Adrian L. Smith 1998-07-14
5714498 Benzimidazole derivatives Paul D. Leeson 1998-02-03
5712285 Pyrrolo-pyridine derivatives Neil Roy Curtis, Paul D. Leeson, Mark Peter Ridgill 1998-01-27
5700809 Pyrrolo-pyridine derivatives Paul D. Leeson, Adrian L. Smith, Mark Peter Ridgill, Raymond Baker, Neil Roy Curtis 1997-12-23
5700802 Furopyridine derivatives Neil Roy Curtis, Paul D. Leeson 1997-12-23
5700941 Octahydronaphthyridine derivatives 1997-12-23